Clinical Trial: Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate Cancer

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699705) titled 'Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate Cancer' on July 02.

Brief Summary: The goal of this prospective observational cohort study is to evaluate the long-term efficacy and safety of ultrahypofractionated proton beam therapy in patients with localized prostate cancer and to identify clinical and treatment-related factors associated with oncologic outcomes and treatment-related toxicity.

The main questions it aims to answer are:

What are the long-term biochemical recurrence-free survival, clinical progression-free survival, overall survival, and acute and late treatment-related toxicity...